Skip to main content
Back to Rebel Fund

Rebel Fund's Biotechnology Portfolio

Browse 4 Biotechnology companies funded by Rebel Fund. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
4
Total Funding in Biotechnology
$6.9M

Biotechnology Portfolio Companies (4)

Export
Artificial Intelligence (AI)BiotechnologyInformation TechnologyMachine LearningReal TimeWeb Apps

Convexia develops AI agents that evaluate drug assets through simulations, clinical profiling, safety prediction, and market analysis.

San Francisco, United States
September 2025
$500K
Pre-Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Biotechnology

Angstrom AI leverages GenAI-based molecular simulations to replace wet lab experiments in pre-clinical drug development.

San Francisco, United States
September 2024
$500K
Pre-Seed

Founder Contacts

30,000+ verified contacts

Artificial Intelligence (AI)Biotechnology

Angstrom AI leverages GenAI-based molecular simulations to replace wet lab experiments in pre-clinical drug development.

San Francisco, United States
September 2024
$500K
Pre-Seed

Founder Contacts

30,000+ verified contacts

BiotechnologyGeneticsHealth CareTherapeutics

Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.

San Francisco, United States
August 2021
$5.4M
Seed

Founder Contacts

30,000+ verified contacts

Explore Rebel Fund's Full Portfolio

View all companies funded by Rebel Fund across every industry and funding stage.

View Full Rebel Fund Portfolio